| |
||
|
Catalogue Number |
Product | Order number / Unit |
| |
||
| 7500 | S-(-)-BZM |
7500.0001: 1 mg per vial 7500.0010: 10 mg per vial Please inquire for customized filling and bulk quantities.
|
|
Precursor for S-(-)-[123/125I]IBZM
|
||
| Molar Mass: 278.35 | ||
| C15H22N2O3 | ||
| [84226-04-0] | ||
| Pale yellow semisolid packaged in dark glass crimp cap vials (7500.0001) or screw cap vials (7500.0010). | ||
| Purity: > 95 % | ||
|
Certificates:
CoA; 1H NMR spectrum |
||
|
Chemical Name: CA index name: Benzamide, N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-hydroxy-6-methoxy-; Benzamide, N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-hydroxy-6-methoxy-, (S)- |
||
|
Synonymes: BZM; S-(-)-2-Hydroxy-6-methoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide |
||
|
Literature: 1. Kung H.F. et al. Dopamine D-2 receptor Imaging Radiopharmaceuticals: Synthesis, Radiolabeling and in Vitro binding of R(+)- and S(-)-3-iodo-2-hydroxy-6-methoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide. J. Med. Chem. 1988, 31, 1039-1043. |
||
| 2. Norinder U. et al. A quantitative structure-activity relationship for some dopamine D2 antagonists of benzamide type. Acta Pharm. Nord. 1992, 4, 73-78. | ||
| date of product catalogue issue: 05 April 2012 | ||
PDF file product list home page search email legal notice
ICP License: 沪ICP备05000469号-1